Elanco Animal Health (ELAN) Asset Writedowns and Impairment (2017 - 2025)

Elanco Animal Health's (ELAN) quarterly Asset Writedowns and Impairment came in at $47.0 million in Q4 2025, up 840.0% year-on-year from $5.0 million in Q4 2024, and up 95.83% quarter-over-quarter from $24.0 million in Q3 2025.

Elanco Animal Health (ELAN) Asset Writedowns and Impairment (2017 - 2025) Analysis & Trends

Elanco Animal Health has disclosed Asset Writedowns and Impairment across 9 years of filings, most recently posting $47.0 million for Q4 2025.

  • Asset Writedowns and Impairment for Q4 2025 came in at $47.0 million, up 840.0% year-over-year; the trailing twelve-month figure through Dec 2025 was $91.0 million (up 75.0% YoY), and the FY2025 annual result was $71.0 million, down 12.35% from the prior year.
  • Asset Writedowns and Impairment came in at $47.0 million for Q4 2025 at Elanco Animal Health, up from $24.0 million in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $275.0 million in Q2 2021 to a low of $5.0 million in Q4 2021.
  • The 5-year median for Asset Writedowns and Impairment is $23.0 million (2022), against an average of $45.8 million.
  • Across the five-year window, Asset Writedowns and Impairment surged 9066.67% in 2021 and slumped 81.48% in 2024, its largest moves.
  • Elanco Animal Health's Asset Writedowns and Impairment stood at $5.0 million in 2021, then soared by 1080.0% to $59.0 million in 2022, then slumped by 54.24% to $27.0 million in 2023, then tumbled by 81.48% to $5.0 million in 2024, then jumped by 840.0% to $47.0 million in 2025.
  • The last three Asset Writedowns and Impairment figures came in at $47.0 million (Q4 2025), $24.0 million (Q3 2025), and $5.0 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Liquidia 5.64 Bn 5.42 Bn 121.79 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 47.00 Mn
Dec 31, 2025 47.00 Mn
Sep 30, 2025 24.00 Mn
Sep 30, 2025 24.00 Mn
Dec 31, 2024 5.00 Mn
Dec 31, 2024 5.00 Mn
Sep 30, 2024 15.00 Mn
Sep 30, 2024 15.00 Mn
Dec 31, 2023 27.00 Mn
Dec 31, 2023 27.00 Mn
Sep 30, 2023 5.00 Mn
Sep 30, 2023 5.00 Mn
Jun 30, 2022 59.00 Mn
Jun 30, 2022 59.00 Mn
Mar 31, 2022 22.00 Mn
Mar 31, 2022 22.00 Mn
Dec 31, 2021 5.00 Mn
Dec 31, 2021 5.00 Mn
Sep 30, 2021 56.00 Mn
Sep 30, 2021 56.00 Mn